Skip to main content
Oaktree Acquisition Corp. III Life Sciences logo

Oaktree Acquisition Corp. III Life Sciences - Investor Relations & Filings

Listed IPO Oct 2024
Ticker · OACC ISIN · KYG6717R1204 US Financial and insurance activities
Filings indexed 47 across all filing types
Latest filing 2025-02-14 Major Shareholding Noti…
Country US United States of America
Listing US OACC · 3 venues

About Oaktree Acquisition Corp. III Life Sciences

https://www.oaktreeacorn.com/

Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company (SPAC), also known as a blank check company. It was established to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or a similar business combination with one or more businesses. The company focuses its search on identifying and partnering with promising enterprises within the life sciences and broader healthcare sector. As a SPAC, it does not have significant operations of its own. It is the third public acquisition vehicle sponsored by an affiliate of Oaktree Capital Management.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-12 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 6, 2025, reporting changes in the company's board of directors and senior management. It specifically details the resignation of a director and the appointment of new directors and officers. There is no financial data or report content, only management changes. According to the filing definitions, announcements of changes in the company's board or senior management fall under Board/Management Information (MANG). The document length is 4769 characters, which is sufficient to contain substantive information about management changes. Therefore, the correct classification is MANG with high confidence.
2025-01-07 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated December 11, 2024. It announces that the holders of the company's units may elect to separately trade the Class A ordinary shares and warrants included in the units starting December 16, 2024. The document includes a press release as an exhibit and does not contain financial statements or detailed financial data. The content is an announcement of a corporate event related to securities trading and structure, not a full financial report or earnings release. Given the nature of the announcement about trading separation of securities and the absence of financial results or management discussion, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-12-11 English
AQR CAPITAL MANAGEMENT LLC
Major Shareholding Notification
2024-11-07 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the partial exercise of an over-allotment option related to an IPO, additional private placement units, and includes an unaudited pro forma balance sheet. The document does not contain a full annual or quarterly report, nor detailed earnings or management discussion. It primarily reports on financing activities related to the IPO and private placements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8357 characters) and detailed financial transaction information support this classification with high confidence.
2024-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.